The five-year contract allows for production of up to 80 million doses at short notice until 2029, CureVac said, adding that those doses could be for the remainder of the current pandemic or future outbreaks.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/BuAfnxO
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Germany agrees deal with CureVac, GSK for mRNA vaccines until 2029
https://ift.tt/xy2vXPZ
No comments:
Post a Comment